Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryAI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Teams that need rapid disease detection alerts and coordinated response pathways.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Viz.ai as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Do not treat a platform-level FDA-cleared-algorithm count as clearance for every pathway; verify the specific disease module, indication, and geography. |
|---|---|
| Privacy | Check imaging, mobile, messaging, and EHR data flows, including notification content, user access, trust-center controls, retention, and business-associate terms. |
| Evidence | Review pathway-specific evidence for time-to-notification, treatment activation, false alerts, missed cases, and outcome measures in comparable hospitals. |
| Workflow | Use when the care pathway has named responders, escalation windows, and specialist confirmation rather than as standalone diagnostic interpretation. |
Viz.ai states its platform is driven by more than 50 FDA-cleared algorithms and supports imaging-driven care coordination; its trust center frames security and privacy diligence for clinical-data deployments.
Not for: Standalone diagnosis without specialist confirmation and workflow governance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.